Detalhe da pesquisa
1.
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 20(1): 110-119, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522967
2.
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme.
J Neurooncol
; 140(3): 559-568, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132165
3.
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme.
Future Oncol
; 14(8): 699-707, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29521523
4.
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
J Neurooncol
; 125(2): 359-67, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423801
5.
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.
Cancers (Basel)
; 14(10)2022 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626029
6.
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
J Thorac Oncol
; 17(9): 1086-1097, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659580
7.
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).
Cancers (Basel)
; 13(11)2021 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204877
8.
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
J Neurol
; 268(8): 2866-2875, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609154
9.
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial).
Eur J Cancer
; 155: 179-190, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388515
10.
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study.
Lung Cancer
; 152: 127-134, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387727
11.
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.
Neuro Oncol
; 23(2): 264-276, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661549
12.
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World.
Drugs Aging
; 37(9): 677-689, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681401
13.
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis.
Clin Cancer Res
; 26(17): 4478-4484, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518098
14.
Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas.
Curr Treat Options Neurol
; 20(2): 3, 2018 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29476361
15.
Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).
Lung Cancer
; 52(1): 89-92, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16483688
16.
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).
Lung Cancer
; 46(1): 99-106, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15364137
17.
Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.
J Thorac Oncol
; 7(8): 1283-90, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653077